Skip to main content
. 2017 Dec 27;9(22):16205–16212. doi: 10.18632/oncotarget.23671

Table 1. Main characteristics of studies included in the meta-analysis.

Author Year Sample size Male/female age Results
Sumiko [27] 2016 82 50/32 64.6 OS LFS
Joji [28] 2017 42 23/19 73 OS
Paola [20] 2015 86 49/37 NA OS LFS
Hideto [26] 2010 80 53/27 70 OS LFS
Jae-Ho [37] 2015 82 53/29 49 OS CIR
Mo XD [36] 2016 78 48/30 38 CIR

Abbreviations: NA: not available, OS: overall survival, LFS: leukemia-free survival, CIR: cumulative incidence of relapse.